Anna Vyborova

Title: Anna Vyborova: Innovator in Cell Targeting Therapies

Introduction

Anna Vyborova is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of therapies targeting cancer cells. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Anna Vyborova holds a patent for "Compositions and methods for cell targeting therapies." This patent includes polypeptide constructs and cells that comprise CDR3 regions of γ9, δ2, or both, which selectively bind to a J-configuration of CD277 on target cells. The disclosure also provides pharmaceutical compositions utilizing these polypeptides or cells, along with methods for employing these compositions in cancer treatment. This patent highlights her commitment to developing effective therapies for challenging medical conditions.

Career Highlights

Throughout her career, Anna has demonstrated a strong focus on research and innovation. She is associated with UMC Utrecht Holding B.V., where she collaborates with other experts in the field. Her work has not only contributed to her own professional growth but has also advanced the collective knowledge in the area of cell targeting therapies.

Collaborations

Anna has worked alongside notable colleagues, including Jürgen Herbert Ernst Kuball and Zsolt Sebestyen. These collaborations have enriched her research and have played a crucial role in the development of her patented technologies.

Conclusion

Anna Vyborova is a trailblazer in the field of biotechnology, with her innovative patent paving the way for new cancer therapies. Her dedication to research and collaboration with esteemed colleagues underscores her impact on the scientific community.